AlzeCure Pharma AB (publ) (STO:ALZCUR)

Market Cap	217.76M +108.1%
Revenue (ttm)	n/a
Net Income	-39.15M
EPS	-0.42
Shares Out	114.91M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	97,631
Average Volume	42,338
Open	1.985
Previous Close	2.020
Day's Range	1.820 - 1.985
52-Week Range	1.500 - 4.950
Beta	-0.09
RSI	45.66
Earnings Date	Feb 26, 2026

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are i...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 11
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ALZCUR